FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4380291222> ?p ?o ?g. }

• W4380291222 abstract "Abstract Introduction While the use of different immunosuppressants has been investigated in immunoglobulin A nephropathy, further investigation is needed to assess the effect of a regimen of mycophenolate mofetil combined with a short course of glucocorticosteroids in the subset of patients with histologically active features. We compared the efficacy and safety of a combined regimen of mycophenolate mofetil and glucocorticosteroids to a conventional regimen of glucocorticosteroids alone in patients with immunoglobulin A nephropathy who have active lesions and major urinary abnormalities. Methods This retrospective study involved 30 immunoglobulin A nephropathy patients with active histological lesions, 15 of whom were treated with both mycophenolate mofetil 2 g/day for 6 months and 3 pulses of 15 mg/kg methylprednisolone, followed by a short tapering schedule of oral prednisone. The control group was made up of the remaining 15 clinically- and histologically-matched patients treated with glucocorticosteroids alone according to a validated schedule, i.e., 1 g of methylprednisolone given intravenously for 3 consecutive days, followed by oral prednisone 0.5 mg/kg every other day for 6 months. At diagnosis, all patients had urinary protein excretion > 1 g/24 h and microscopic hematuria. Results At the end of the first year of follow-up (30 patients) and after 5 years (17 patients), there were no differences between the two groups in terms of urinary abnormalities and functional parameters. Both regimens achieved a statistically significant decrease in 24-h urinary protein excretion ( p < 0.001) and a reduction of microscopic hematuria. However, the mycophenolate mofetil-based regimen allowed a cumulative sparing dose of 6 g of glucocorticosteroids. Conclusion In this single center study on immunoglobulin A nephropathy patients with active lesions and major urinary abnormalities and at increased risk of glucocorticosteroid-related complications, a mycophenolate mofetil-based regimen demonstrated similar outcomes in terms of complete response and relapse (at 1 and 5 years) compared to a conventional glucocorticosteroid-based protocol, while achieving a consistent reduction of glucocorticosteroid cumulative dose. Graphical Abstract" @default.
• W4380291222 created "2023-06-13" @default.
• W4380291222 creator A5012705049 @default.
• W4380291222 creator A5017039749 @default.
• W4380291222 creator A5030143277 @default.
• W4380291222 creator A5043758235 @default.
• W4380291222 creator A5044090579 @default.
• W4380291222 creator A5066865082 @default.
• W4380291222 creator A5086035399 @default.
• W4380291222 date "2023-06-12" @default.
• W4380291222 modified "2023-10-01" @default.
• W4380291222 title "The steroid-sparing effects of a mycophenolate mofetil-based regimen in the management of immunoglobulin A nephropathy in patients with histologically active lesions: A comparison with a control cohort receiving conventional therapy" @default.
• W4380291222 cites W1894073864 @default.
• W4380291222 cites W1981156403 @default.
• W4380291222 cites W1987519860 @default.
• W4380291222 cites W1997948783 @default.
• W4380291222 cites W2010602089 @default.
• W4380291222 cites W2011665041 @default.
• W4380291222 cites W2026823633 @default.
• W4380291222 cites W2036651304 @default.
• W4380291222 cites W2056583648 @default.
• W4380291222 cites W2105803357 @default.
• W4380291222 cites W2107050894 @default.
• W4380291222 cites W2110869035 @default.
• W4380291222 cites W2125136564 @default.
• W4380291222 cites W2186629139 @default.
• W4380291222 cites W2254149092 @default.
• W4380291222 cites W2339791834 @default.
• W4380291222 cites W2354455325 @default.
• W4380291222 cites W2588777848 @default.
• W4380291222 cites W2589016395 @default.
• W4380291222 cites W2738388315 @default.
• W4380291222 cites W3200553460 @default.
• W4380291222 cites W4247172809 @default.
• W4380291222 cites W4361852002 @default.
• W4380291222 doi "https://doi.org/10.1007/s40620-023-01636-6" @default.
• W4380291222 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37306917" @default.
• W4380291222 hasPublicationYear "2023" @default.
• W4380291222 type Work @default.
• W4380291222 citedByCount "1" @default.
• W4380291222 countsByYear W43802912222023 @default.
• W4380291222 crossrefType "journal-article" @default.
• W4380291222 hasAuthorship W4380291222A5012705049 @default.
• W4380291222 hasAuthorship W4380291222A5017039749 @default.
• W4380291222 hasAuthorship W4380291222A5030143277 @default.
• W4380291222 hasAuthorship W4380291222A5043758235 @default.
• W4380291222 hasAuthorship W4380291222A5044090579 @default.
• W4380291222 hasAuthorship W4380291222A5066865082 @default.
• W4380291222 hasAuthorship W4380291222A5086035399 @default.
• W4380291222 hasBestOaLocation W43802912221 @default.
• W4380291222 hasConcept C126322002 @default.
• W4380291222 hasConcept C126894567 @default.
• W4380291222 hasConcept C134018914 @default.
• W4380291222 hasConcept C141071460 @default.
• W4380291222 hasConcept C2778033501 @default.
• W4380291222 hasConcept C2778720950 @default.
• W4380291222 hasConcept C2780372218 @default.
• W4380291222 hasConcept C2781184683 @default.
• W4380291222 hasConcept C2781413609 @default.
• W4380291222 hasConcept C2909935303 @default.
• W4380291222 hasConcept C2911091166 @default.
• W4380291222 hasConcept C555293320 @default.
• W4380291222 hasConcept C71924100 @default.
• W4380291222 hasConcept C77411442 @default.
• W4380291222 hasConcept C90924648 @default.
• W4380291222 hasConceptScore W4380291222C126322002 @default.
• W4380291222 hasConceptScore W4380291222C126894567 @default.
• W4380291222 hasConceptScore W4380291222C134018914 @default.
• W4380291222 hasConceptScore W4380291222C141071460 @default.
• W4380291222 hasConceptScore W4380291222C2778033501 @default.
• W4380291222 hasConceptScore W4380291222C2778720950 @default.
• W4380291222 hasConceptScore W4380291222C2780372218 @default.
• W4380291222 hasConceptScore W4380291222C2781184683 @default.
• W4380291222 hasConceptScore W4380291222C2781413609 @default.
• W4380291222 hasConceptScore W4380291222C2909935303 @default.
• W4380291222 hasConceptScore W4380291222C2911091166 @default.
• W4380291222 hasConceptScore W4380291222C555293320 @default.
• W4380291222 hasConceptScore W4380291222C71924100 @default.
• W4380291222 hasConceptScore W4380291222C77411442 @default.
• W4380291222 hasConceptScore W4380291222C90924648 @default.
• W4380291222 hasFunder F4320324041 @default.
• W4380291222 hasLocation W43802912221 @default.
• W4380291222 hasLocation W43802912222 @default.
• W4380291222 hasOpenAccess W4380291222 @default.
• W4380291222 hasPrimaryLocation W43802912221 @default.
• W4380291222 hasRelatedWork W177202516 @default.
• W4380291222 hasRelatedWork W1969533474 @default.
• W4380291222 hasRelatedWork W1993230048 @default.
• W4380291222 hasRelatedWork W2026992146 @default.
• W4380291222 hasRelatedWork W2386867642 @default.
• W4380291222 hasRelatedWork W2388115823 @default.
• W4380291222 hasRelatedWork W2896700811 @default.
• W4380291222 hasRelatedWork W2897787860 @default.
• W4380291222 hasRelatedWork W3082549382 @default.
• W4380291222 hasRelatedWork W4380291222 @default.
• W4380291222 isParatext "false" @default.
• W4380291222 isRetracted "false" @default.
• W4380291222 workType "article" @default.